Bruce Feinberg, DO, Speaks About Clinical Pathways in Oncology Care
Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says that there is a tremendous amount of waste in the system. "Waste in the system is created by ineffective technology and claims processing that is very cumbersome for both payers and providers," says Dr. Feinberg.
This video was taken on November 16 at AJMC's Translating Evidence-Based Research Into Value-Based Decisions in Oncology.
The annual report was published in the March 30 issue of the Journal of the National Cancer Institute. The report was co-authored by experts from the North American Association of Central Cancer Registries, the American Cancer Society, CDC, and the National Cancer Institute.
The "Know Your Tumor" initiative of the Pancreatic Cancer Action network refers newly diagnosed patients to Perthera, which provides a unique service to ensure timely tissue collection, molecular diagnostic testing, and a report with recommendations for the oncologist.
Knowledge is power, as was the case with a doctoral student at MIT whose keen interest in his own medical data resulted in the diagnosis and excision of a brain tumor. But are all health systems ready to share patients' data with them?
Research published by a team of Italian scientists in the Journal of the National Institute of Cancer shows that a 13-gene panel blood test for microRNAs could be a cost-effective screening tool for lung cancer, compared with low-dose CT, which is expensive.
To mark its 20th year of publication, The American Journal of Managed Care has invited guest contributors to comment on the state of healthcare from their perspective. This month, Karen Ignagni, MBA, president and CEO of America’s Health Insurance Plans and consistently rated as one of healthcare’s most important voices, writes how health plans are supporting value-based care and promoting consumer choice.